North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Results
Looking for
Bortezomib
found
17 matches
Formulary items
6 matches
Sub Section Title / notes
1 match
Open monograph to display formulary status
BNF Category
Bortezomib
Malignant disease and immunosuppression - Bortezomib - 08.01.05
Daratumumab
(Darzalex
®
)
Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
Lenalidomide
Malignant disease and immunosuppression - Lenalidomide, pomalidomide, and thalidomide - 08.02.04
Panobinostat
Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
Pomalidomide
(Imnovid
®
)
Malignant disease and immunosuppression - Lenalidomide, pomalidomide, and thalidomide - 08.02.04
Selinexor
(Nexpovio
®
)
Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
Links
Link to Drug Section
Link to document
NICE TA129: Multiple myeloma - bortezomib (08.01.05)
NICE TA228: Bortezomib and thalidomide for the first‑line treatment of multiple myeloma (08.01.05)
NICE TA228: Bortezomib and thalidomide for the first‑line treatment of multiple myeloma (08.02.04)
NICE TA311: Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation (08.01.05)
NICE TA370: Bortezomib for previously untreated mantle cell lymphoma (08.01.05)
NICE TA427: Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib (08.01.05)
NICE TA427: Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib (08.02.04)
NICE TA586: Lenalidomide plus dexamethasone for multiple myeloma after 1 treatment with bortezomib (08.02.04)
NICE TA897: Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma (08.01.05)
NICE TA974: Selinexor with bortezomib and dexamethasone for previously treated multiple myeloma (08.01.05)
SubSection Titles / notes
Bortezomib
- (08.01.05)
